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ABSTRACT
Background : Searching for extracoronary atherosclerosis in patients
with documented coronary artery disease (CAD) is essential because the
detrimental link between cardiac, renal, carotid and peripheral arterial
diseases are common and atherosclerosis is well known as a polydistrectual disease Objectives: To identify the prevalence of renal artery
stenosis (RAS), carotid artery atherosclerosis (CAA) and/or peripheral
arterial disease (PAD) in patients
with proven CAD and to illustrate
their risk factors and to clarify the
clinical, non invasive maneuvers for
their diagnosis as most of them are
either silent or minimally symptomatizing. Study design: Cross section
study. Patients and methods: One
hundred and thirty six cases (92
11
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males and 44 females) with mean
age of 66.2± 6.8 years, who were
subjected in the preceding year to
coronary angiography for acute coronary syndrome and were coming for
follow up. Clinical examination
stressing on some atherosclerosis
risk factors (blood pressure, blood
glucose and serum lipids), symptoms
and signs that may be specific for ischemia in different vascular territories, intermittent claudication, abdominal bruit, carotid bruit, ankle
brachial index (ABI), serum potassium, serum creatinine. Electrocardiography, echocardiography, Duplex
ultrasonography for carotid, renal
and lower limb arteries were
stressed upon. The examined cases
were then grouped into those with either RAS, CAA, PAD versus cases
without extracoronary involvement.
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Results: Significant RAS (Duplex US
scan) was detected in 33.82%, CAA
in 29.41%, PAD in 27.94% and in
only 8.82% no significant extracoronary stenosis was detected. Significant high plasma glucose and smoking in PAD, while hypertension and
dyslipidemia in RAS. Male gender
and increased waist circumference
were significantly higher in CAA and
significant lowering of ABI in PAD.
Conclusion: Atherosclerosis involving extracoronary territories is prevailing in patients with documented
CAD and screening by US duplex is
mandatory to patients undergoing or
had undergone coronary interventions.
Key word: extracoronary atherosclerosis, coronary artery disease.

INTRODUCTION
Atherosclerosis is a diffuse disease, though it affects certain regions of the vascular bed preferentially (1). In line with aging
population, the prevalence of CAD,
PAD, CAA is increasing. Poly vascular atherosclerosis (PVA) existing in
several territories usually has adverse effects on cardiovascular morbidities (2).
Searching for extracoronary ath-

erosclerosis in patients with proven
CAD is essential because the detrimental link between cardiac and renal pathology in RAS is well documented (3).
Presence and severity of incidental RAS is an independent predictor
of morbidity and mortality in atherosclerotic patients regardless of the
mode of treatment of CAD (1, 4).
Tobe and associates (2007) (5), defined RAS as narrowing of the lumen
of renal artery ≥ 50% while atherosclerotic
renovascular
disease
(ARVD) as a combination of RAS
and renal ischemia.
RAS is not only a cause of accelerated, resistant HTN and a leading
cause of renal impairment but according to Tami et al (1995) (6) may
be a cause of unstability of CAD
and crescendo angina pectoris, CVD
and flash pulmonary oedema.
In the past, RAS was under recognized and under diagnosed. With
improving noninvasive imaging techniques, the diagnosis is currently
more frequently established (7). Diagnosis of RAS is necessary as early as possible because meaningful
recovery of kidney function is limited
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once renal fibrosis is established (8).

SUBJECTS AND METHODS

Gupta and associates (2010) (9) ad-

One hundred and thirty six cases
(92males and 44 females) with mean
age of 66.2± 6.8 years, who had undergone during the preceding year
coronary angiography with stenting
or CABG for acute coronary syndrome and were coming for follow up
with no specific symptoms which
were attributed to their CAD state.
Full clinical examination was done
with special stress on symptoms and
signs suggestive of vascular ischemia in other extracoronary vascular
territories, including symptoms and
signs of PAD (intermittent claudication, cold limbs, femoral bruit, dystrophic changes. Hypertension and
its severity as defined by the Joint
National Committee 2003 (JNC 7)

vised early recognition and management of RAS.
Many methods are of help in identifying the magnitude and location of
the vascular territories involved in
patients with CAD. Xie and coworkers (2012) (10) investigated the relationship between ankle brachial index (ABI) and severity of ARAS and
found that ABI is a valuable predictive index of midrange to severe
ARAS. YY and coworkers (2010) (11)
concluded that renal duplex scanning (RDS) might still be the diagnostic procedure of choice for
screening patients for ARAS.

(12) was stressed upon; abdominal

Aims:
It was aimed to identify the prevalence of renal artery stenosis (RAS),
carotid artery atherosclerosis (CAA)
and/or peripheral artery disease
(PAD) in patients with proven CAD
and to illustrate their risk factors.
Also to clarify the clinical, non invasive maneuvers for their diagnosis
as most of them are either silent or
minimally symptomatizing.
Design : Cross- section study.

bruit, captopril induced rise of serum
creatinine, flash pulmonary oedema,
hypokalemia. Giddiness, dizziness,
transient ischemic attacks (TIA), carotid bruit and CNS examination
were stressed upon. The study protocol was approved by the cardiology ethical committee and informed
consents were obtained.
ABIs were measured according to
the method recommended by the
American Heart Association, using
MANSOURA MEDICAL JOURNAL
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ABI form device (VP 1000 Colin, Komaki , Japan) in both arms and ankles using an Oscillo metric method
measuring the systolic BP (Xie et al
2012). Fasting plasma glucose, post
75 gm glucose challenge tests on
two occasions was carried out together with lipogram. The diagnosis
of DM, IFG, IGT were assessed according to the recommendation of
the ADA (1998) (13). The criteria for
dyslipidemia were according to the
National Cholesterol Education Program (1993) (14).
- 12 lead ECG for evidences of
CAD, ischemia, ventricular hypertrophy, arrhythmias
- Echocardiography for evidence of diastolic dysfunction
using transmitral Doppler flow
and graded as mild (grade 1;
impaired relaxation, reversed
E/A ratio), moderate (grade 2;
pseudonormal decrease deceleration time), severe (restrictive pattern). Systolic dysfunction stressing on Ejection
Fraction (EF) and Fibrous
Shortening (FS) and LVH.
Duplex scanning of the carotid arteries were undertaken where the
carotid arteries were examined in
both transverse and sagital planes.

Four Doppler variables were considered as reliable predictors for the
presence and severity of carotid vascular disease; peak systolic velocity
(PSV), end diastolic velocity (EDV),
spectral broadening, peak systolic
velocity ratio; which is the peak systolic velocity in the internal carotid
artery divided by the peak systolic
velocity in the common carotid
Renal duplex (RD); after a minimum of 6 hours fasting and following
a three day at least of low fibre diet
and without smoking. RD were performed utilizing the anterior, antrolateral and lumber approach to examine the kidney, main renal artery and
its branches as well as intrarenal
flow by senior expert sonographer
who was blinded to patient clinical
data and utilizing the machine Toshiba SAL- 270. The presence of any of
the following six abnormalities were
considered indicative for the presence of RAS according to Soulez et
al (2000) (15).
- Direct visualization of stenosis
in the mean RA or its branches
with combined B- mode and
colour Doppler ultrasound.
- Peak systolic velocity in renal
artery more than 100 cm/ sec
- Turbulent flow in the post ste-
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notic area.
- Renal resistance index more
than 0.68 (peak systolic velocity- end diastolic velocity/ peak
systolic velocity * 100) (5).
- A change in the renal resistance index greater than 5%
between right and left mean renal artery.
Duplex scanning of the arteries of
the lower limbs were scanned with
higher frequency transducer at the
origin of the profunda femories, superfacial femoral artery, popliteal
and proximal tibial arteries.
Statistical analysis: was performed by using the statistical package for social science program
(SPSS) version "16". The qualitative
data were presented as frequency
and percentages. The quantitative
data were examined by using Kalmogrov-Smirnov test to test for normal
distribution of the data and when
parametric, expressed as mean and
standard deviation. Student t test
was used, to test for difference in
normally distributed quantative data
between the two groups. MannWhitney-µ test was used for comparison between two groups when data
are not normally distributed. Signifi-

15

cance was considered when P value
less than 0.05.

RESULTS
After clinical examination and duplex scanning, the examined cases
were categorized into 4 groups
- Group 1: Cases with ARAS (46
cases) (33.82%).
- Group 2: Cases with PAD (38
cases) (27.94%).
- Group 3: Cases with CAA (40
cases) (29.41%).
- Group 4: Cases with no significant extracoronary atherosclerosis (NO.ECA) (12 cases)
(8.82%).
Cases of combined stenosis in
more than one territory were
not included among the 136
cases evaluated in the present
study.
Significant RAS as proven by duplex US were detected in 46 cases
out of the 136 examined being the
commonest extracoronary atherosclerosis (33.82%). CAA was detected in 29.41%. PAD was detected in
27.94%. Age of the studied groups
revealed insignificant differences.
Gender: 80% were males in CAA.
Smoking was significantly elevated
in the RAS group (73.9%), PAD
MANSOURA MEDICAL JOURNAL
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(63.2%) and 37.5% in CAA. The
maximum WC was in the group of
CAA (120± 10.5 cm) and revealed
higher significant values in comparison to the group of RAS and PAD.
TIA was common only in CAA. The
highest prevalence of intermittent
claudication (52.6%) was in the
group of PAD and the ABI was lowest (0.76± 0.2) also in the group of
PAD. FPG was significantly higher in
RAS, PAD. The post 75 gm plasma
glucose was significantly higher in
RAS, PAD and CAA groups in relation to ECA- control group. Significant dyslipidemia was detected in
65.2% of cases of RAS. Serum potassium was lowest in the group of
RAS. Cases with > 20% significant
rise of serum creatinine was detected in RAS group alone and insignificant rise in CAA and PAD. Positive
captopril rise of s. creatinine was
highest in the group of RAS (34.7%).
It was higher than in the group of
CAAD (25%) than in the group of
PAD (21.05%).
Risk factors revealed significant
elevation of blood glucose, smoking
in all the ECAD. Dyslipidemia and

HTN were significantly elevated in
RAS. Male gender and WC showed
specific higher levels in CAA.
ABI were 0.9± 0.1 in RAS, 0.86 in
CAA and was 0.76± 0.2 in PAD and
was 1.1± 0.2 in the non extracoronary group. Bruit was not significantly detected in any group.
Comparing the 4 studied groups
as regards BP, plasma glucose revealed insignificant difference but
SBP and DBP and smoking were
significantly higher in the RAS group.
Captopril induced renal impairment
were significantly higher in the group
of RAS.
The ECG results demonstrated
LVH in RAS group only, significant
arrhythmias and ischemia were not
detected. Echocardiography: EF was
significantly lower in RAS followed
by CAA and PAD. Diastolic dysfunction grade I was observed in all the
studied groups, while grade II was
evident in 26.08% of cases of RAS
only, while grade III diastolic dysfunction was not significantly evident
in any group.
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DISCUSSION
The primary aim of the study was
to evaluate the magnitude of extracoronary ischemia stressing on
ARAS, CAA and PAD in patients
with proven CAD and to identify the
diagnostic role of non- invasive approach.
Diagnosing ischemia in extracoronary territories is a bit difficult and
needs a high index of clinical suspicion. Diagnosis of ARAS as early as
possible is mandatory because
meaningful recovery of kidney function is limited once renal fibrosis is
established (8). Although it is stated
that ARAS is under diagnosed yet in
the present study clinically, there
was significant elevation in SBP, diastolic BP and significant captopril- in-

duced renal impairment together
with significant dyslipidimia and hypokalemia. Tobe and coworkers
(2007) (5) considered that hypokalemia with HTN are among the clinical
clues to suggest ARVD.
Persistent HTN, smoking and
dyslipidimia are common in RAS. El
Fiky and Saleh (2001) (16) found no
statistical significant difference between patients with and those without ARVD as regards age, sex, DM.
In our study and of El Fiky and Saleh
2001 (16) smoking was frequently
associated with RAS. The present
results are in agreement with Dzielinska et al (2007) (17) and Salehi et
al (2011) (18) who reported that traditional risk factors have a limited potential for predicting RAS.
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All groups revealed significant
lowering of ABI. This is in agreement
with Fishbane et al (1995) (19) and
Newman et al (1991) (20) and is
confirmatory to Xie et al 2012(10)
who found that ABI is a valuable predictive index of midrange to severe
ARAS. Newman et al (1999) (20)
demonstrated that ABI is not only a
marker for diagnosing PAD, but also
for generalized atherosclerotic disease.
In the present study RAS was
present in 33.82%. This is lower than
that reported by El Fiky and Saleh
(2001) (16) who had reported 59.1%,
but is higher to that reported by Vetrovec et al (1998) (21) in hypertensive patients with CAD undergoing
coronary angiography (20%). Our results on RAS are in agreement with
the finding of Harding et al dating to
1992 (22) in patients undergoning
cardiac catheterization (30%) and
are confirmatory to those of Cianci et
al (2012) (23), who found that up to
50% of patients with diffuse atherosclerosis have ARVD.
In the present study extracoronary atherosclerotic affection was
detected in 91.18% and in only
8.82% of the studied cases there

19

was no significant extracoronary affection. Przewlocki et al (2009) (2)
detected significant atherosclerosis
in extracoronary arterial territories in
more than one third (36%) of the patients with documented CAD.
Screening patients for RAS can
be achieved by a variety of noninvasive methods, each has its merits and disadvantages. The renal duplex as performed in the present
work has the advantage of providing
anatomic and functional data (16).
Duplex scanning has been applied widely to assess the extracranial carotid arteries where it has become the non invasive investigation
of choice. Conventional angiography
although is the standarad method for
determining the presence of RAS,
yet the invasiveness and technical
difficulties make it a less favourable
scanning modality for RAS (24).
Duplex renal artery scanning was
the method adopted in the present
study and the presence of one or
more of the accepted six abnormalities reported by Soulez et al (2001)
(15) was considered indicative for the
presence of RAS. The present results are in line with Coen et al
(2003) (25) who concluded that colMANSOURA MEDICAL JOURNAL
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our duplex ultrasonography is a valid
method of investigating population at
risk of RAS.
The present finding are confirmatory to YY and coworkers (2010)
(11), who concluded that RA duplex
scanning might still be the diagnostic
procedure for scanning suspected
patients, because it is inexpensive,
convenient, capable to detect severity and avoid the dangers of contrast
induced nephropathy.
Salehi et al (2011) (18) after evaluating the relationship between distribution of lesions in coronary artery
tree and ARAS by performing simultaneous renal angiography following
coronary angiography found RAS in
26.2% and CAD in 69.2%. The
present finding of RAS in 33.82% of
our cases by RA duplex could be related to difference in the studied cases being older in the present study
(66.2± 6.8 years) and inclusion of
any atherosclerotic narrowing ≥ 50%
and on the whole the conclusion of
Salehi et al (2011) (18) of simultaneous renal angiography following coronary angiography may be justified.
Park et al (2010) (26) recommended
the use of preoperative angiography
for RAS as a routine test before

CABG.
Systemic atherosclerosis was detected in any of the three examined
vascular territories. This is in agreement with Przewlocki et al (2009) (2),
Rapezzi and Gallo (2010) (27) who
stated that atherosclerosis is a polydistrectual disease. Also Badr et al
(1999) (28) proved clinically and by
duplex scanning that carotid and
lower limb arterial disease are associated with a significant percentage
of ARAS.

CONCLUSION
Extracoronary atherosclerosis is
common in CAD and cases of CAD
should be considered as a polyvascular problem as CAD is not a single
atherosclerotic medical problem, but
is a member of the gloomy orchestra
of atherosclerosis. Early screening
for RAS, CA stenosis and/or PAD
has to be meticulously undertaken to
save CAD patients not only from CV
effects but also to maintain their renal, cerebral and limb vitality.
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